Search Results - Rasenacks, J.

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

    Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3 by Pianko, S., Zeuzem, S., Chuang, W.-L., Foster, G. R., Sarin, S. K., Flisiak, R., Lee, C.-M., Andreone, P., Piratvisuth, T., Shah, S., Sood, A., George, J., Gould, M., Komolmit, P., Thongsawat, S., Tanwandee, T., Rasenack, J., Li, Y., Pang, M., Yin, Y., Feutren, G., Jacobson, I. M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    493 Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year

    493 Phase III comparison of telbivudine vs lamivudine in HBeAg-positive patients with chronic hepatitis B: Efficacy, safety, and predictors of response at 1 year by Gane, E., Lai, C.L., Liaw, Y.E., Thongsawat, S., Wang, Y., Cheng, Y., Heathcote, J., Rasenacks, J., Bzowej, N., Naoumov, N., Chao, G., Fielman, B., Brown, N.

    Published in Journal of hepatology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: